Artificial intelligence and Drug Development

The scientist working on this project advocate for the use of Ai in drug development. They believe the new technology has the potential to transform the pharmaceutical industry. Especially when it comes to research on the aging process and how we can prolong it.

The research team uses a combination of Reinforcement Learning (RL) and Generative Adversarial Networks (GANs) to better drug development. They show that this process is more effective than the previous Hit to Lead (H2L) method. This fact is most obvious when we compare the time it takes the H2L and AI to develop new drugs. With the old method, it took scientists up to three years to develop a new drug. AI can do the entire process in 46 days. This time-frame can significantly alter drug development in the future and it may help millions of people whit untreatable conditions.